Literature DB >> 29198211

Association of Cx43 rs2071166 polymorphism with an increased risk for atrial septal defect.

Ruoyi Gu1, Wei Sheng1, Xiaojing Ma1, Guoying Huang1.   

Abstract

Atrial septal defect is one of the most common CHD. The pathogenesis of atrial septal defect still remains unknown. Cx43 is the most prevalent connexin in the mammalian heart during development. Its genetic variants can cause several CHD. The aim of our study was to investigate the association of genetic variations of the Cx43 with sporadic atrial septal defect. A total of 450 paediatric patients were recruited, including 150 cases with atrial septal defect and 300 healthy controls. The promoter region of Cx43 was analysed by sequencing after polymerase chain reaction. All data were analysed by using the Statistic Package for Social Science 19.0 software. The frequency of the single nucleotide polymorphism rs2071166 was significantly higher in atrial septal defect cases than in healthy controls. The CC genotype at rs2071166 site in Cx43 was correlated with an increased risk for atrial septal defect (p<0.0001, odds ratio=3.891, 95% confidence interval 1.948-7.772) and the C allele was positively correlated with atrial septal defect (p=0.007, odds ratio=1.567, 95% confidence interval 1.129-2.175). In conclusion, our results confirmed that rs2071166 in Cx43 may be relevant with an increased atrial septal defect risk.

Entities:  

Keywords:  zzm321990 Cx43zzm321990 ; atrial septal defect; single nucleotide polymorphism

Mesh:

Substances:

Year:  2017        PMID: 29198211     DOI: 10.1017/S1047951117002001

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  1 in total

1.  GJA1 Gene Polymorphisms and Topographic Distribution of Cranial MRI Lesions in Cerebral Small Vessel Disease.

Authors:  Jing Zhang; Qian You; Junlong Shu; Qiang Gang; Haiqiang Jin; Meng Yu; Wei Sun; Wei Zhang; Yining Huang
Journal:  Front Neurol       Date:  2020-11-25       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.